Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Flávia Oliveira de Almeida Marques da Cruz

Flávia Oliveira de Almeida Marques da Cruz

University of Brasilia, Brazil

Title: Validation of an Educative Manual for Patients with Breast Cancer submitted to Radiation Therapy

Biography

Biography: Flávia Oliveira de Almeida Marques da Cruz

Abstract

Printed materials are important strategies for supporting educative activities, since they help the individual to assimilate the amount of information transmitted. The objective of this research was to validate of an educative manual for breast cancer patients undergoing radiation therapy. Descriptive methodological research. A minimum agreement rate (AR) of 80% was considered to guarantee the validation. The data were collected from October to December 2017, by means of assessments tools for two different groups of participants: 17 experts in the theme area of the educative manual, and 12 women that received RT previously to treat breast cancer. Only two items of the assessment tool for the experts, one related to the manual's ability to promote behavioral and attitude changes and the other related to the extent of its use for other health services, obtained AR < 80%, and were reformulated based on the participants' suggestions and in the literature. All other items were considered appropriate and/or complete appropriate in the three blocks proposed for the experts: objectives - 89%, structure and form - 93%, and relevance - 93%; and good and/or very good in the five blocks of analysis proposed for patients: objectives - 100%, organization - 100%, writing style - 100%, appearance - 100%, and motivation - 100%. The appearance and content validation of the educative manual proposed were attended to. The educative manual was considered relevant and pertinent and may contribute to the understanding of the therapeutic process by breast cancer patients during RT.